본문 바로가기

Multifaceted Roles of Chloroquines in Gastrointestinal Disorders and Beyond

문서 유형
연구출판물 · 리뷰논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
COMPREHENSIVE PHYSIOLOGY16(4) · 2026
피인용
Web of Science 0Scopus 0
FWCI (Scopus)
0
JCR IF
JCR 2024 5.2
ISSN
2040-4603

저자

  1. 정시현제1저자Pusan Natl Univ, Coll Pharm, Busan, South Korea
  2. 김은수Pusan Natl Univ, Coll Pharm, Busan, South Korea
  3. Kim, Yong SungWonkwang Univ, Digest Dis Res Inst, Sch Med, Iksan, South Korea
  4. 임은옥교신저자Pusan Natl Univ, Coll Pharm, Busan, South Korea

초록

Chloroquine (CQ) and hydroxychloroquine (HCQ), originally developed as antimalarial agents, have demonstrated broad pharmacological activity across diverse diseases. As weak lipophilic bases, both compounds accumulate in acidic organelles such as lysosomes, interfering with their function and disrupting key cellular processes. This review explores the therapeutic applications of CQ and HCQ in gastrointestinal (GI) pathologies and beyond, with a focus on molecular and cellular mechanisms. In inflammatory bowel disease, CQ and HCQ modulate autophagy, suppress proinflammatory cytokines, and alter gut microbiota composition, contributing to barrier protection and immune regulation. In colitis-associated colorectal cancer, both agents inhibit tumor development, enhance the efficacy of 5-fluorouracil, and reverse drug resistance through autophagy blockade. CQ additionally potentiates PI3K/mTOR-targeted therapies and natural product-based treatments in gastric cancer. Moreover, CQ decreases GI motility, potentially delaying gastric emptying, and both agents modulate other GI disorders, including Cheilitis granulomatosa, Whipple's disease, Sjögren's syndrome, and dysphagia. Furthermore, the lysosomotropic properties of CQ may serve as a therapeutic adjunct to improve the efficacy of conventional antibiotics against Mycobacterium tuberculosis. The pharmacodynamic profiles of CQ and HCQ underscore their potential as modulators of immune, microbial, and intracellular signaling networks. While accumulating evidence supports their repositioning across inflammatory and neoplastic GI diseases, further mechanistic studies and clinical validation are required to refine their therapeutic applications.

키워드

autophagychloroquinecolorectal cancerhydroxychloroquineinflammatory bowel disease

식별자

Scopus EID
2-s2.0-105045384413
WoS UID
001829130400001